Prediction of chronic renal allograft dysfunction from evaluations of TGFβ1 and the renin-angiotensin system

Clinical and Experimental Nephrology

Volumn 7, Issue 3, 2003, Pages 238-242

  Yamada, Kenichi ^a   Hatakeyama, Emiko ^a   Arita, Seiji ^a   Sakamoto, Kaoru ^a   Kashiwabara, Hidehiko ^a   Hamaguchi, Kinichi ^a  

^a SAKURA NATIONAL HOSPITAL   (Japan)

Author keywords

Chronic allograft dysfunction; Prediction; Renin angiotensin system; TGF 1

Indexed keywords

ANGIOTENSIN I; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GRAFT FAILURE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MALE; PLASMA RENIN ACTIVITY; PROSPECTIVE STUDY; REFERENCE VALUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSITIVITY AND SPECIFICITY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENAL; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENIN; RENIN-ANGIOTENSIN SYSTEM; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

EID: 0141995579     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-003-0237-z     Document Type: Article

References (30)

1. Cook DJ. Long-term survival of kidney allografts. Clin Transpl 1987;277-85.
2. Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, et al. Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 1991;214:679-88.
3. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605-12.
4. Matas AJ, Burke JF Jr, DeVault GA Jr, Monaco A, Pirsch JD. Chronic rejection. J Am Soc Nephrol 1994;4(8 Suppl):S23-9.
5. Racusen LC, Solez K, Colvin R. Fibrosis and atrophy in the renal allograft: interim report and new directions. Am J Transplant 2002;2:203-6.
6. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999;10:67-81.
7. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495-508.
8. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
9. Shihab FS, Tanner AM, Shao Y, Weffer MI. Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int 1996;50:1904-13.
10. Horvath LZ, Friess H, Schilling M, Borisch B, Deflorin J, Gold LI, et al. Altered expression of transforming growth factor-βs in chronic renal rejection. Kidney Int 1996;50:489-98.
11. 1 in transplant patients with chronic allograft nephropathy. Kidney Int 1999;56:714-9.
12. Boratyńska M. Urine excretion of transforming growth factor-β1 in chronic allograft nephropathy. Ann Transplant 1999;4:23-8.
13. Border WA, Noble NA. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension 1998;31:181-8.
14. Khanna A, Kapur S, Sharma V, Li B, Suthanthiran M. In vivo hyperexpression of transforming growth factor β1 in mice: stimulation by cyclosporine. Transplantation 1997;63:1037-9.
15. Modena FM, Hostetter TH, Salahudeen AK, Najarian JS, Matas AJ, Rosenberg ME. Progression of kidney disease in chronic renal transplant rejection. Transplantation 1991;52:239-44.
16. Yamada K, Gunji Y, Hishikawa E, Kashiwabara H, Sakamoto K, Arita S, et al. Possible involvement of endothelin in post transplant acute tubular necrosis. I: Studies in renal transplant patients. Transplantation 1994;57:1137-9.
17. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et al. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:416-771.
18. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGFβ1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-27.
19. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
20. Libby P, Hansson GK. Biology of disease: involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
21. Furness PD 3rd, Maizels M, Han SW, Cohn RA, Cheng EY. Elevated bladder urine concentration of transforming growth factorβ1 correlates with upper urinary tract obstruction in children. J Urol 1999;162:1033-6.
22. , Hellmick B, Schellner M, Schatz H, Pfeiffer A. Activation of transforming growth factor-beta 1 in diabetic kidney disease. Metabolism 2000;49:353-9.
23. Rivarola EW, Moyses-Neto M, Dantas M, Da-Silva CG, Volpini R, Coimbra TM. Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy. Braz J Med Biol Res 1999;32:1525-8.
24. Sharma VK, Bologa RM, Xu GP, Li B, Mouradian J, Wang J, et al. Intragraft TGF-β1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996;49:1297-303.
25. lsoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Hayry P. Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 1992;41:155-60.
26. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine. Transplantation 1998;12:1736-40.
27. Antonipillai I, Wang Y, Horton R. Tumor necrosis factor and interleukin-1 may regulate renin secretion. Endocrinology 1990;126:273-8.
28. Bataillard A, del Rey A, Klusman I, Arditi GM, Besedovsky HO. Interleukin-1 stimulates aldosterone secretion: involvement of renin, ACTH, and prostaglandins. Am J Physiol 1992;263:R840-4.
29. Davies M. The mesangial cell: a tissue culture view. Kidney Int 1994;45:320-7.
30. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, et al. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994;24:195-204.